IIM- IDIOPATHIC INFLAMMATORY MYOPATHIES
Clinical trials for IIM- IDIOPATHIC INFLAMMATORY MYOPATHIES explained in plain language.
Never miss a new study
Get alerted when new IIM- IDIOPATHIC INFLAMMATORY MYOPATHIES trials appear
Sign up with your email to follow new studies for IIM- IDIOPATHIC INFLAMMATORY MYOPATHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on lupus and scleroderma in early trial
Disease control Recruiting nowThis early-stage study tests a new treatment called QT-019C, which uses specially engineered immune cells (CAR T-cells) to target and attack faulty cells that cause autoimmune diseases like lupus, scleroderma, and vasculitis. The treatment is given as a one-time infusion and aims…
Matched conditions: IIM- IDIOPATHIC INFLAMMATORY MYOPATHIES
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 26, 2026 08:47 UTC
-
New drug CC312 tested in severe autoimmune patients
Disease control Recruiting nowThis early-stage study tests the safety of a new drug, CC312, in 6 adults with lupus, myositis, or scleroderma that has not responded to standard treatments. The main goal is to check for side effects, not to cure the disease. Participants receive multiple doses of the drug and a…
Matched conditions: IIM- IDIOPATHIC INFLAMMATORY MYOPATHIES
Phase: EARLY_PHASE1 • Sponsor: CytoCares Inc • Aim: Disease control
Last updated May 19, 2026 11:47 UTC